Published in Prostate on February 01, 1998
Correlation of prostatic urethral angle with the severity of urinary symptom and peak flow rate in men with small prostate volume. PLoS One (2014) 0.80
Serum prostate-specific antigen as a predictor of prostate volume and lower urinary tract symptoms in a community-based cohort: a large-scale Korean screening study. Asian J Androl (2013) 0.78
Prostatic urethral angle might be a predictor of treatment efficacy of α-blockers in men with lower urinary tract symptoms. Drug Des Devel Ther (2014) 0.77
Does urinary bladder shape affect urinary flow rate in men with lower urinary tract symptoms? ScientificWorldJournal (2014) 0.75
Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nat Genet (1994) 2.55
A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol (1999) 2.13
Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate (1996) 1.85
Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable? BJU Int (2003) 1.50
Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-up. J Cardiovasc Risk (1996) 1.46
Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers. G Ital Cardiol (1999) 1.40
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene (2006) 1.39
Prevalence and correlates of echocardiographic determined left ventricular hypertrophy in 2318 asymptomatic middle-aged men: the ECCIS project. Epidemiolgia e Clinica della Cardiopatia Ischemica Silente. G Ital Cardiol (1997) 1.22
Molecular resolution of marine turtle stock composition in fishery bycatch: a case study in the Mediterranean. Mol Ecol (1998) 1.05
Short-term all-cause mortality and its determinants in elderly male populations in Finland, The Netherlands, and Italy: the FINE Study. Finland, Italy, Netherlands Elderly Study. Prev Med (1996) 1.00
Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH. Eur Urol (2001) 0.99
The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients. Arterioscler Thromb Vasc Biol (1998) 0.97
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia. Prostate (1998) 0.96
Determinants of all causes of death in samples of Italian middle-aged men followed up for 25 years. J Epidemiol Community Health (1987) 0.95
Physical activity at work and job responsibility as risk factors for fatal coronary heart disease and other causes of death. J Epidemiol Community Health (1985) 0.94
Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology. J Pathol (1999) 0.94
Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. Eur Urol (1992) 0.93
Heat shock protein-90, IL-6 and IL-10 in bladder cancer. Anticancer Res (2001) 0.91
The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry. Am J Cardiol (2001) 0.90
Influence of contractile reserve and inducible ischaemia on left ventricular remodelling after acute myocardial infarction. Heart (2003) 0.89
Prediction of all causes of death as a function of some factors commonly measured in cardiovascular population surveys. Prev Med (1983) 0.88
Plant extracts in BPH. Minerva Urol Nefrol (1993) 0.88
Leiomyosarcoma of urinary bladder: personal experience in 3 cases over a 10-year period. Arch Ital Urol Androl (1997) 0.88
Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation. BJU Int (2004) 0.87
Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer. J Exp Clin Cancer Res (2000) 0.87
Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines. Prostate (1996) 0.87
Prediction of cardiac events after uncomplicated acute myocardial infarction by clinical variables and dobutamine stress test. J Am Coll Cardiol (1999) 0.87
Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization. J Cell Physiol (2009) 0.87
Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma. Cancer (2000) 0.87
Blood pressure changes as predictors of future mortality in the seven countries study. J Hum Hypertens (1991) 0.86
Indexes of obesity and all-causes mortality in Italian epidemiological data. Prev Med (1993) 0.86
Diet and 20-y mortality in two rural population groups of middle-aged men in Italy. Am J Clin Nutr (1989) 0.85
Prognosis of lean and fat hypertensives. Cardiology (1988) 0.85
Mean levels and distributions of some cardiovascular risk factors in Italy in the 1970's and the 1980's. The Italian RIFLE Pooling Project. Risk factors and life expectancy. G Ital Cardiol (1995) 0.85
Human renal cell carcinoma as a hormone-dependent tumor. Cancer Res (1978) 0.85
Type 1 diabetes mellitus and hyperadrenocorticism in a ferret. Vet Res Commun (2010) 0.85
Transforming growth factor-beta pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma. Anal Quant Cytol Histol (2001) 0.84
Importance of premeal injection time in insulin therapy: Humalog Mix25 is convenient for improved post-prandial glycemic control in type 2 diabetic patients with Italian dietary habits. Acta Diabetol (2003) 0.84
Insulin-like growth factor-I and -II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens. Steroids (1998) 0.84
Efficacy and safety of a hemostatic puncture closure device with early ambulation after coronary angiography. Angio-Seal Investigators. Am J Cardiol (1998) 0.84
Time changes in predictability of coronary heart disease in an Italian aging population. Cardiology (1993) 0.84
The prediction of coronary heart disease mortality as a function of major risk factors in over 30 000 men in the Italian RIFLE pooling Project. A comparison with the MRFIT primary screenees. The RIFLE research group. J Cardiovasc Risk (1994) 0.84
Transforming growth factor-beta expression in prostate neoplasia. Anal Quant Cytol Histol (2000) 0.84
The predictive role of systolic, diastolic and mean blood pressures on cardiovascular and all causes of death. J Hypertens (1989) 0.84
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens. J Clin Endocrinol Metab (2001) 0.84
Cancer stem cells in prostate adenocarcinoma: a target for new anticancer strategies. J Cell Physiol (2008) 0.83
Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH). J Androl (1998) 0.83
Prognostic value of dobutamine echocardiography early after uncomplicated acute myocardial infarction: a comparison with exercise electrocardiography. J Am Coll Cardiol (1997) 0.82
Acquired cystic kidney disease: the hormonal hypothesis. Urology (1993) 0.82
Angiotensin-converting enzyme gene polymorphism is not associated with coronary atherosclerosis and myocardial infarction in a sample of Italian patients. Eur J Clin Invest (1998) 0.81
Long-term prediction of coronary heart disease mortality in two rural Greek populations. Eur Heart J (1993) 0.81
A case of human polyomavirus Bk infection in a patient affected by late stage prostate cancer: could viral infection be correlated with cancer progression? Int J Immunopathol Pharmacol (2007) 0.81
Chlamydia trachomatis genitourinary infections: laboratory diagnosis and therapeutic aspects. Evaluation of in vitro and in vivo effectiveness of azithromycin. J Chemother (1994) 0.81
Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study. Eur Urol (1990) 0.81
Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia. Eur Urol (1997) 0.81
Electrocardiographic Minnesota code findings predicting short-term mortality in asymptomatic subjects. The Italian RIFLE Pooling Project (Risk Factors and Life Expectancy). G Ital Cardiol (1997) 0.81
Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS Project). Am J Cardiol (1993) 0.80
1457 years of microsurgical experience. Plast Reconstr Surg (1997) 0.80
The relationship of cardiovascular risk factors measured at different ages to prediction of all-cause mortality and longevity. Arch Gerontol Geriatr (2008) 0.80
The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis. Clin Genet (2000) 0.80
Comparative total mortality in 25 years in Italian and Greek middle aged rural men. J Epidemiol Community Health (1998) 0.80
Diet of two rural population groups of middle-aged men in Italy. Int J Vitam Nutr Res (1988) 0.80
Steroid receptors and hormone responsiveness of human prostatic carcinoma. Prostate (1982) 0.79
The seven countries study in Japan. Twenty-five-year experience in cardiovascular and all-causes deaths. Jpn Heart J (1995) 0.79
Spontaneous changes of systolic blood pressure as predictors of future fatal events. Italian Research Group of the Seven Countries Study. Am J Hypertens (1990) 0.79
[Role of nitric oxide in the urogenital system: physiology and pathology]. Minerva Urol Nefrol (2000) 0.79
The relation of chronic diseases to all-cause mortality risk--the Seven Countries Study. Ann Med (1997) 0.79
Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first". J Invasive Cardiol (2000) 0.79
Health consequences of road accidents: insights from local health authority registries. Ann Ig (2013) 0.79
Progestational therapy in human renal carcinoma and steroid receptors. J Steroid Biochem (1977) 0.79
Twenty-five-year prediction of stroke deaths in the seven countries study: the role of blood pressure and its changes. Stroke (1996) 0.78
Androgenic and antiandrogenic control on epidermal growth factor, epidermal growth factor receptor, and androgen receptor expression in human prostate cancer cell line LNCaP. Prostate (1995) 0.78
Hormone-refractory prostate cancer? Anti-androgen withdrawal and intermittent hormone therapy. Scand J Urol Nephrol (1999) 0.78
Cardiovascular risk factors predicting all causes of death in an occupational population sample. Int J Epidemiol (1988) 0.78
New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma. Int J Clin Pract (2006) 0.78
Correspondence re: Ghosh A and Heston WDW. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 91:528-539, 2004. J Cell Biochem (2004) 0.78
Hormonal pattern in prostatic carcinoma following orchidectomy: 5-year follow-up. Br J Urol (1977) 0.78
Transforming growth factor beta 1 and androgen receptors in prostate neoplasia. Anal Quant Cytol Histol (2000) 0.78
Plasma testosterone and androstenedione after orchiectomy in prostatic adenocarcinoma. Clin Endocrinol (Oxf) (1973) 0.78
Laparoscopic transperitoneal right adrenalectomy for 'large' tumors. Urol Int (2008) 0.78
Human kidney steroid receptors. J Steroid Biochem (1976) 0.78
In vitro study of a double infection by herpes simplex virus type 2 and Chlamydia trachomatis. New Microbiol (1996) 0.78
Twenty-five year mortality from coronary heart disease and its prediction in two Croatian cohorts of middle-aged men. Eur J Epidemiol (1995) 0.78
The prognostic value of DNA content in patients with prostatic carcinoma. Eur Urol (1992) 0.77
Coronary mortality and its prediction in samples of US and Italian railroad employees in 25 years within the Seven Countries Study of cardiovascular diseases. Int J Epidemiol (1995) 0.77
Relationship of some risk factors with typical and atypical manifestations of coronary heart disease. Cardiology (1998) 0.77
Renal cancer steroid receptors: biochemical basis for endocrine therapy. Eur Urol (1979) 0.77
Is there always a role for radical prostatectomy in the treatment of localized prostate cancer? Minerva Urol Nefrol (1995) 0.77